Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine.
about
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiersThree New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage TherapyIdentification and characterisation of an iron-responsive candidate probioticEffects of mesalamine (5-aminosalicylic acid) on bacterial gene expression.Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityThe role of bacteria in the pathogenesis of inflammatory bowel diseaseAntioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin.Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.Anti-inflammatory effects of urocanic Acid derivatives in models ex vivo and in vivo of inflammatory bowel disease.Oestrogens and Crohn's disease: the missed link.Role of flagellin in Crohn's disease: emblematic of the progress and enigmas in understanding inflammatory bowel disease.p38(MAPK): stress responses from molecular mechanisms to therapeutics.Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.Bacterial induction of proinflammatory cytokines in inflammatory bowel disease.The intestinal microbiota and chronic disorders of the gut.MCPIP-1, Alias Regnase-1, Controls Epithelial Inflammation by Posttranscriptional Regulation of IL-8 Production.Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.RETRACTED: Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis.DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid.Lipopolysaccharide-regulated production of bone sialoprotein and interleukin-8 in human periodontal ligament fibroblasts: the role of toll-like receptors 2 and 4 and the MAPK pathway.Mucosa-associated microbiota dysbiosis in colitis associated cancer.Hispidulin-7-O-Neohesperidoside from Cirsium japonicum var. ussuriense Attenuates the Production of Inflammatory Mediators in LPS-Induced Raw 264.7 Cells and HT-29 Cells.Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells.Quercetin 3,7-O-dimethyl ether from Siegesbeckia pubescens suppress the production of inflammatory mediators in lipopolysaccharide-induced macrophages and colon epithelial cells.Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis.Olive oil polyphenols reduce oxysterols -induced redox imbalance and pro-inflammatory response in intestinal cells.
P2860
Q24611219-AAA13EA7-8EF0-4781-80B2-AD2132BA478FQ28550170-BF796986-A5F2-4FB8-9C80-9D94C5B30F26Q28743610-A747AC24-D79E-4011-9362-5FCF07F60918Q33406895-0765D7B0-E548-4C5F-BA15-E826184B3E30Q33515113-A24B73C2-6B4A-40DC-A55C-2691CC207205Q33958858-9101B698-594B-4ADE-9F1A-0E522DC1066AQ34048001-A5958862-8324-48F1-83C9-A9DCBC4A0C58Q34206639-5D57E92A-3CE7-44B8-BB1B-A9BEDAB9E22CQ34836490-9BF4A739-AA1F-42B7-8BA8-773F18DEE585Q35191960-D8CF9AE7-F765-43EE-8EDF-97F706D0626DQ37118457-E12CBF7C-70F4-4DF3-8B61-C296FD7F3A95Q37153104-EF71CCCC-65D7-4FEC-90D8-4FC9193B5272Q37162661-89F2F0BE-0EFC-4B37-BB18-73681E042A1AQ37358180-89841303-4A4B-4331-9D91-779614464043Q37576462-AE53E718-BA64-48CA-9970-D5BF88B7E680Q37594944-0921EF6F-8201-4606-A988-D285A75A34E8Q37789694-A9CEC77B-6EF7-4DA5-B97E-BEF1464219F1Q37918323-C54D0F72-1010-47CF-8218-2D3D2C2B90B1Q40473602-D51A5B62-18AC-46AF-AE76-DC840804EAC9Q42714629-D59A5E6D-51A8-42D2-949A-981B20A1FF98Q43179829-D7A7B3FB-BDD7-494B-9984-2E4C70AB9132Q46215033-CF47F2E7-22C4-4D86-925B-0ED0F62994A4Q46284774-570BCCAB-F1A8-45ED-BD82-B4A1DF9B5855Q46306507-BB4C6442-D4AE-490C-91BF-3E7B9E5161C0Q47161841-69828DCD-1A3B-4781-A2BD-CFD0A4AFF2B7Q50498990-AC541F5B-51D7-4626-8D39-1D0F26A99D2EQ51314089-9567EF67-53B7-4CA8-A439-42E8D4DD224CQ53539411-F85F1AAD-2A2D-4694-84AF-4827BA8BEB70Q55265714-EC32537C-347D-4702-BE5F-51DA2B544B1E
P2860
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Characterization of epithelial ...... its inhibition by mesalamine.
@en
Characterization of epithelial ...... its inhibition by mesalamine.
@nl
type
label
Characterization of epithelial ...... its inhibition by mesalamine.
@en
Characterization of epithelial ...... its inhibition by mesalamine.
@nl
prefLabel
Characterization of epithelial ...... its inhibition by mesalamine.
@en
Characterization of epithelial ...... its inhibition by mesalamine.
@nl
P2093
P2860
P356
P1476
Characterization of epithelial ...... d its inhibition by mesalamine
@en
P2093
C Anthony Hart
Carol L Roberts
John E Corkill
Jonathan M Rhodes
Mumtaz Virji
Shirley L Smith
Sreedhar Subramanian
P2860
P304
P356
10.1002/IBD.20296
P577
2008-02-01T00:00:00Z